rivastigmine has been researched along with Contact Dermatitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haque-Hussain, S; Khoo, ABS | 1 |
| Adam, DN; Greenspoon, J; Herrmann, N | 1 |
| Pregelj, P | 1 |
1 review(s) available for rivastigmine and Contact Dermatitis
| Article | Year |
|---|---|
Transdermal rivastigmine: management of cutaneous adverse events and review of the literature.
Topics: Administration, Cutaneous; Alzheimer Disease; Cholinesterase Inhibitors; Dermatitis, Allergic Contact; Dermatitis, Contact; Humans; Medication Adherence; Phenylcarbamates; Rivastigmine; Transdermal Patch | 2011 |
2 other study(ies) available for rivastigmine and Contact Dermatitis
| Article | Year |
|---|---|
A differential diagnosis for annular lesions: contact dermatitis to transdermal rivastigmine patches.
Topics: Aged; Dermatitis, Contact; Diagnosis, Differential; Humans; Male; Memory Disorders; Neuroprotective Agents; Rivastigmine; Transdermal Patch | 2018 |
Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Dermatitis, Contact; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neuropsychological Tests; Patient Compliance; Phenylcarbamates; Prospective Studies; Rivastigmine; Transdermal Patch; Treatment Outcome; Vomiting | 2012 |